Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Book value per share

Book value per share at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$50.16+21.0%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$15.79+60.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$11.70-34.9%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.98-0.6%
LQD
Liquidia CorporationLQDA
$1.07+84.0%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$7.98+27.6%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×—
P/S5.6×+1.8×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

total stockholders equity/weighted shares diluted=$7.35

Based on the most recent quarter.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's book value per share?
Kiniksa Pharmaceuticals International, plc (KNSA) reported book value per share of $7.35 in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's book value per share changed year-over-year?
Kiniksa Pharmaceuticals International, plc's book value per share increased by 22.3% year-over-year, from $6.01 to $7.35.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's book value per share?
Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's book value per share has grown at a 7.3% compound annual growth rate (CAGR), from $5.04 to $7.19.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.